[A new basic agent, prospidin, in the therapy of rheumatoid arthritis. Research on its clinical effectiveness in a controlled and double-blind trial].
Benenson E V, Nemtsov B F, Maksimov T A, +2 more·Revmatologiia (Moscow, Russia)
Abstract not available